How to Dose Tirzepatide the Right Way

You've just started at 2.5 mg and it feels like nothing is happening

This is one of the questions our prescribers hear most weeks. The 2.5 mg starting dose exists specifically to give your digestive system time to adapt. At this strength, nausea, diarrhoea and other gastrointestinal effects are far more manageable than they would be if treatment launched straight to a therapeutic level. Most people spend four weeks here before moving up. Some people feel side effects even at this stage; others feel very little. Both are normal.

After that first month, your prescriber will typically move you to 5 mg. If you want to read more about what to expect at that point, the Mounjaro 5 mg page covers what the clinical evidence says about this stage. From 5 mg the ladder continues: 7.5, 10, 12.5, and finally 15 mg, with roughly four weeks at each rung before a further increase, always subject to how you're tolerating the current dose. Your prescriber may hold you at a given strength longer if side effects are still settling. That's not a setback; it's the schedule working as intended.

The NHS patient information for tirzepatide on NHS.uk sets out the general dose-escalation framework and is worth reading alongside your Patient Information Leaflet. If anything in your PIL conflicts with what you read elsewhere, the PIL wins, it reflects your specific product batch and licence.

What the titration schedule actually looks like in practice

People often ask whether they can speed up the schedule if side effects are mild. The short answer is: not without a prescriber's say-so. The four-week minimum between increases is baked into the licenced prescribing framework because the gut-hormone effects of tirzepatide take time to stabilise. Rushing the schedule doesn't improve results; it typically increases the chance of nausea, vomiting or worse.

Going the other way (staying at a dose longer) is clinically reasonable and fairly common. If you're managing well at 10 mg and your prescriber agrees your progress is good, there's no obligation to push to 12.5 mg or 15 mg. The maximum licensed dose is 15 mg, but not everyone needs to reach it to get meaningful results. SURMOUNT-1, the pivotal trial involving thousands of adults with obesity, found that participants on the 10 mg and 12.5 mg maintenance doses also achieved substantial average weight reductions, even though the 15 mg arm produced the highest figures.

A practical note on timing: your weekly injection day matters less than keeping it consistent. Pick a day that fits your week, some people anchor it to the start of the working week so it never slides into a holiday or a weekend away. Whatever day you choose, try to stick to it. If you shift by a day occasionally, the PIL gives guidance on the acceptable window; your prescriber is the right person to ask if you're unsure in a specific situation.

Dose-change decisions belong to your prescriber, here's why

The titration schedule printed above is the licensed framework. What it doesn't capture is the clinical judgement that sits around it. Your prescriber reviews your weight, any reported side effects, any relevant health changes, and your own account of how the current dose feels before signing off a dose increase. At nume, that review happens before every repeat order, a real clinician reads your update, not an automated system.

This matters most at the higher end of the schedule. Stepping from 10 mg to 12.5 mg, or from 12.5 mg toward the maximum, requires evidence that the lower dose is well tolerated and that the increase is appropriate for you. The same applies if you're transferring from another provider; you'd need to show evidence of your current dose before a further increase is considered. This isn't bureaucracy for its own sake, it's the clinical safeguard that separates legitimate prescribing from the counterfeit supply chains the MHRA has repeatedly warned about. Fake pens have no titration logic built in, no prescriber behind them, and no recourse if something goes wrong.

If you're still working out which strength you're likely to reach, the 5 mg and 10 mg pages explain what the evidence says about those maintenance levels specifically. The weight-loss treatments page gives an overview of the broader treatment options available through nume if you're still deciding.

Side effects along the dose ladder and when to get medical help

GI side effects (queasiness, loose stools, constipation, bloating, burping) are most noticeable after a dose increase and usually ease within one to two weeks as your body adjusts. They tend to be milder if you're eating smaller portions, staying well hydrated, and avoiding fatty or heavily processed foods, particularly in the days after a new pen starts.

More serious effects are uncommon but need prompt attention. Severe stomach pain that radiates toward your back, with or without vomiting, can signal acute pancreatitis, the MHRA highlighted this specifically in its January 2026 Drug Safety Update for GLP-1 medicines. Don't wait if that symptom appears. Similarly, signs of a serious allergic reaction, significant dehydration from persistent vomiting or diarrhoea, or gallbladder-type pain all need same-day medical assessment, not a message to your online pharmacy. UK patients can report suspected side effects through the MHRA Yellow Card scheme.

If you're unsure whether a symptom is dose-related or something else, our aftercare team is available seven days a week. For anything that feels urgent or serious, call 111 or attend A&E. Our FAQs page covers some of the most common between-dose questions in more detail.

Ready to talk through the schedule with a prescriber? Speak to our prescribers via a free consultation, same-day clinical review, no waiting list.